Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00901472 · ClinicalTrials.gov registry record
Sleep Disordered Breathing and Diabetes
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 105
- Enrollment target
NCT00901472: Completed study, sponsored by University of Chicago.
NCT00901472 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 105 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00901472 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 105 participants
- Enrollment target
Study Summary
The hypothesis of this study is: sleep disordered breathing (SDB), specifically, obstructive sleep apnea, is associated with poorer glucose in the existing type 2 diabetic condition. In an exploration of this hypothesis, the investigators hope to provide evidence linking SDB to increased severity of disease in the type 2 diabetic patient. By doing so, the investigators ultimately seek to support investigating the use of SDB interventions as an additional method of care in the treatment of type 2 diabetes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-12 |
What the finished NCT00901472 record still lists
NCT00901472 is an observational study that tracks outcomes without assigning an intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00901472 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00901472 about?
NCT00901472 is a clinical study titled "Sleep Disordered Breathing and Diabetes". The hypothesis of this study is: sleep disordered breathing (SDB), specifically, obstructive sleep apnea, is associated with poorer glucose in the existing type 2 diabetic condition. In an exploration of this hypothesis, the investigators hope to provide evidence linking SDB to increased severity o...
What is the current status of trial NCT00901472?
This trial is currently completed. The enrollment target is 105 participants. The study started on 2007-02. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00901472?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia